Objective: Chronic rhinosinusitis (CRS) refractory to therapeutic intervention may involve a particularly resistant infection known as a bacterial biofilm. Critical to biofilm formation is the microbial process of quorum sensing whereby microbes secrete factors that regulate the expression of microbial genes involved in biofilm formation, persistence, and virulence. Here, we review recent work demonstrating that the bitter taste receptor T2R38, expressed on the apical surface of the sinonasal epithelium, serves a sentinel role in eavesdropping on microbial quorum-sensing communications and regulates localized innate biocidal defenses. Furthermore, studies investigating whether cilia are necessary for T2R38 expression and function in the upper airway are presented.
INTRODUCTION
Chronic rhinosinusitis (CRS) affects more than 35 million Americans with an aggregated cost of $8 billion annually, accounting for one in five antibiotic prescriptions in adults. [1] [2] [3] [4] Patients with CRS have significant decrements in quality of life, both in disease-specific areas and in general health. In fact, patients requiring sinus surgery demonstrate worse scores for physical pain and social functioning than those suffering from chronic obstructive pulmonary disease, congestive heart failure, or angina. 5 Although the etiology of the disease is not known, environmental exposure to pathogens combined with an underlying genetic predisposition is proposed. 6 It remains controversial whether sinonasal infection or local inflammation is the root cause of rhinosinusitis, but there is little argument that the presence of bacteria in the sinonasal cavity contributes to the pathophysiology and that bacteria in the form of biofilms contribute to recalcitrant CRS, requiring prolonged medical therapy and revision surgery. [7] [8] [9] [10] Biofilms are complex sessile three-dimensional structures of bacteria that are attached to a living or an abiotic surface. 11 They are embedded in an extracellular matrix and exhibit a distinct phenotype and genotype when compared to their planktonic counterpart. 12 Biofilm formation develops in a stepwise fashion that starts with attachment to a surface. Following the attachment, there is the formation of a microbial microcolony; once this reaches a certain density, biofilm formation ensues. This life cycle is regulated by a process referred to as quorum sensing whereby in response to multiple environmental factors, microbes secrete chemical signals known as autoinducers or quorum-sensing molecules, which regulate the expression of microbial genes involved in biofilm formation, persistence, virulence, and other life-cycle processes.
The sinonasal cavity is at the front line of defense of the respiratory tract. [15] [16] [17] Host-pathogen interactions occur with every breath containing aerosolized fungal spores, bacteria, and virus particles. 17 However, in most individuals, the upper and lower airways remain free of infection. This is largely due to the multiple first-line innate immune mechanisms that work in concert to defend the sinonasal epithelium.
The primary physical defense is the process of mucociliary clearance. 15, 16, 18 The airway surface is lined by a mucus gel made up of cross-linked glycosylated mucin macromolecules produced by airway secretory cells; the carbohydrate side chains of the mucins create sticky binding sites that trap airway pathogens and particulates in the mucus. 15, 16, 19, 20 The spatially and temporally coordinated beating of ciliated epithelial cells then transports the debris-and pathogen-laden mucus from the upper and lower respiratory passages toward the throat, where it is cleared by swallowing or expectoration. 15, 16, 19 Mucociliary clearance is complemented by the secretion of antimicrobial compounds, including peptides such as lysozyme, lactoferrin, and defensins 21 -as well as the generation of reactive oxygen and nitrogen species (ROS/RNS), which can have direct antibacterial, antifungal, and antiviral effects 22, 23 ( Fig. 1 ). As mentioned above, multiple investigations have demonstrated an association between sinonasal bacterial biofilms and recalcitrant chronic rhinosinusitis. [7] [8] [9] Although there are many challenges surrounding the diagnosis and clinical management of biofilms, one question that we have been focusing on is whether there are certain patients who are genetically predisposed to form biofilms. Recent work from our lab linking sinonasal innate immunity with bitter (T2R) taste receptors may answer this question. [24] [25] [26] [27] [28] [29] Bitter Taste Receptors: New Players in Airway Innate Immunity
Evidence of taste receptor expression in the airway first came in 2009, when researchers demonstrated that human bronchial cells express T2Rs that, when activated with known bitter agonists such as denatonium benzoate, stimulate calcium responses to increase ciliary beating. 30 Interestingly, these T2Rs are found within motile cilia. 30 Although motile cilia were previously thought to be responsible only for the movement of fluid, as in the airway 31 and during embryonic development, 32 this study demonstrated that motile cilia are also "chemosensory organelles" and the authors hypothesized that T2Rs protect the lower airway against inhaled noxious irritants. 30 Subsequent to the identification of taste receptors in lower airway epithelial cells, our lab reported on the expression of both bitter (T2R) 29 and sweet (T1R) 33 taste receptors in the human sinonasal epithelium and described robust innate immune pathways regulated by these receptors. One bitter taste receptor that was focused in this work was T2R38; as in the lower airway, it is localized to motile cilia. 29, 33 When sinonasal ciliated epithelial cells were stimulated with known T2R38-specific agonists, such as the bitter-tasting compound phenylthiocarbamide (PTC), they exhibited calciumdependent activation of nitric oxide (NO) synthase (NOS), driving robust NO production. 29 As expected for a taste receptor, NO production depended on two important components of the canonical taste signal transduction cascade, 29 the TRPM5 ion channel 34 and phospholipase C isoform b2
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; however, unexpectedly PTC stimulation of NO was independent of the canonical taste G-protein, a-Gustducin. 36 Nitric oxide production by airway epithelial cells, including ciliated cells, is believed to be important for preventing airway infection 37, 38 because the NO radical and its derivatives can damage bacterial membranes, enzymes, and DNA 23, 39 ( Fig. 1) . The NO produced during T2R38 activation in sinonasal epithelial cells in vitro was found to diffuse into the airway surface liquid and be directly bactericidal against P. aeruginosa. 29 Additionally, NO increases ciliary beat frequency by activating guanylyl cyclase and protein kinase G, which directly phosphorylates ciliary proteins. 31 The initial T2R38 study 29 also identified two major P. aeruginosa quorum-sensing molecules, N-butyryl-Lhomoserine lactone (C4HSL) and N-3-oxo-dodecanoyl-Lhomoserine lactone (C12HSL), 40 as physiologically relevant, endogenous T2R38 agonists. 29 Sinonasal epithelial cells stimulated directly with these quorum-sensing molecules or with conditioned medium from wild type P. aeruginosa produced NO in a T2R38-dependent manner. However, conditioned medium from a P. aeruginosa strain that lacks these quorum-sensing molecules (DlasI, DrhlI PAO-JP2 41 ) did not activate NO production. Because many types of gram-negative bacteria secrete this specific type of quorum-sensing molecule, 40 T2R38 is likely part of a general surveillance mechanism to detect invading gram-negative bacteria. A schematic of the T2R38 innate immune pathway elucidated by this work is illustrated in Figure 2 .
Human T2R38 functionality is altered by several well-studied polymorphisms in the TAS2R38 gene. 42, 43 Two polymorphisms are common in Caucasian Fig. 1 . Mucociliary clearance and respiratory epithelial innate immunity. Inhaled pathogens, such as viruses, bacteria, and fungal spores, are trapped by mucus secreted by goblet cells of the respiratory epithelium. These trapped microbes are then removed from the airway by the process of mucociliary transport, the airway's primary physical innate defense against inhaled pathogens and irritants. Constant beating of motile cilia drives the pathogenladen mucus toward the oropharynx, where it is then cleared out of the airway by expectoration or swallowing. Mucociliary transport is complemented by more direct mechanisms of pathogen inactivation and/or killing, including generation of ROS and RNS and the production of antimicrobial peptides. ROS 5 reactive oxygen species; RNS 5 reactive nitrogen species.
populations: one encodes a functional T2R38 and the other encodes a nonfunctional T2R38. These polymorphisms result in different amino acids at positions 49, 262, and 296. The functional T2R38 contains proline (P), alanine (A), and valine (V) residues and the nonfunctional T2R38 contains alanine (A), valine (V), and isoleucine (I) at these positions, respectively. 42 Loss of the V at the third position of the AVI variant likely prevents receptor activation. 42, 43 Homozygous AVI/AVI individuals (30% frequency in Caucasians) are non-tasters for T2R38-specific agonists such as PTC and 6-propyl-2-thiouracil (PROP). 42 Homozygous PAV/PAV individuals (20% frequency in Caucasians 42 ) are supertasters who perceive PTC and PROP as intensely bitter. Heterozygote PAV/ AVI individuals have varying intermediate taste levels. 42, 43 These natural T2R38 variants were experimentally exploited by growing primary sinonasal cells from genotyped PAV/PAV supertasters and AVI/AVI nontasters. Nitric oxide-dependent responses correlated with these polymorphisms. PAV/PAV supertaster cells had much higher levels of NO production, increased mucociliary clearance, and more efficient bacterial killing in response to either PTC or acyl-homoserine lactones (AHLs) compared with cells from AVI/PAV heterozygote or AVI/AVI nontaster individuals.
29 TAS2R38 polymorphisms alter how efficiently sinonasal epithelial cells respond to gram-negative bacteria. 29, 33 These findings with regard to T2R38 in human sinonasal innate immunity are summarized in Table I .
This initial study also found that PAV/PAV supertasters had a lower frequency of gram-negative sinonasal infection than PAV/AVI or AVI/AVI patients with lower levels of T2R38 function. 29 Further clinical studies by our group as well as others have validated the relevance of TAS2R38 genotype to sinonasal disease. 25, 27, 44 A retrospective study 25 was first carried out in which TAS2R38 genotyping was performed on sinonasal tissue samples from 28 patients who had undergone primary functional endoscopic sinus surgery (FESS). Of these patients, 3.6% were PAV/PAV, 50% were PAV/AVI, and 46% were AVI/AVI, which was significantly different from the expected distributions of 20% PAV/PAV, 50% PAV/AVI, and 30% AVI/AVI (P < 0.043 by v 2 analysis). 25 Only one patient out of 28 was a PAV/PAV supertaster, suggesting that supertasters are less likely to need surgical intervention for CRS. In a subsequent prospective study of TAS2R38 genotype in 70 patients undergoing primary FESS at the same institution, 27 there was a statistically significant difference in the frequency of AVI and PAV alleles compared with the general population. Distributions of AVI/AVI, AVI/PAV, and PAV/PAV alleles were 37%, 54%, and 8.5%, respectively, in the CRS patients compared with 29%, 51%, and 20%, respectively, in the general regional population (P < 0.0383 by v 2 analysis). 27 No significant differences were found in the allele distribution with respect to allergies, asthma, nasal polyposis, aspirin sensitivity, diabetes, smoking exposure, or other risk factors, suggesting that TAS2R38 is an independent risk factor for CRS requiring FESS Another study was carried out with the goal of verifying if taste receptor polymorphisms correlate with CRS. Two separate Canadian CRS populations were compared with control populations, 44 using previously collected pooling-based genome-wide association data that was screened for single-nucleotide polymorphisms (SNPs) in taste receptors, including the TAS2R38 I296V (rs10246939) thought to underlie the difference in functionality between PAV and AVI variants. A difference in I296V frequency of 11% and 15% in the two CRS groups compared with control individuals was found, confirming that this SNP is associated with CRS. Three other missense variants in TAS2R genes were associated with CRS (frequency difference 10% between CRS and control), one in TAS2R14 (rs1015443) and two in TAS2R49 (rs12226920 and rs12226919). 45 Roles for T2R14 or T2R49 in sinonasal immunity require further research. ) signal that activates NOS-dependent NO production. NO production has two distinct effects: an increase in ciliary beating and mucociliary transport, and NO diffuses directly into the airway surface liquid, where it directly permeabilizes and kills bacteria. AHL 5 acyl-homoserine lactone; NO 5 nitric oxide; NOS 5 nitric oxide synthase. Laryngoscope 127: January 2017
Cohen: T2R38 and CRS: T2R38 Genetics and Chronic Rhinosinusitis
Current Study Hypothesis
Multiple studies have demonstrated that patients with CRS have disrupted sinonasal epithelium with goblet cell hyperplasia and decreased ciliation (Fig. 3) . Prior work has shown that environmental insults such as exposure to tobacco smoke as well as inflammation impairs cilia formation and disrupts cilia function, which may contribute to CRS. [45] [46] [47] The hypothesis tested here is that cilia are not only critical to drive mucociliary clearance but are needed for T2R38 expression and function. To test this hypothesis, primary human sinonasal air-liquid interface (ALI) cultures were utilized. These cultures are initially established in submersion conditions where the epithelial cells are not ciliated. 48 Once tight junctions are formed, the cultures are transitioned to an ALI; over the ensuing 2 weeks, cilia form, typically first appearing around day 10.
MATERIALS AND METHODS

Sinonasal ALI Cultures
Patients were recruited from two institutions with full approval of both institutional review boards. Informed consent was obtained during the preoperative clinic visit or in the preoperative waiting room. Selection criteria for recruitment were patients undergoing sinonasal surgery. Exclusion criteria included a history of systemic diseases such as Wegner's; sarcoid; cystic fibrosis; immunodeficiencies; and use of antibiotics, oral corticosteroids, or antibiologics (e.g., omalizumab) within 1 month of surgery. Sinonasal mucosal specimens were acquired from residual clinical material obtained during sinonasal surgery and transported to the laboratory in saline placed on ice. Air-liquid interface cultures were established from human sinonasal epithelial cells enzymatically dissociated human tissue, as previously described, 29, 33 and grown to confluence in tissue culture flasks (75 cm 2 ) with proliferation medium consisting of Dulbecco's Modified Eagle Medium (DMEM)/Ham's F-12 and bronchial epithelial basal medium (BEBM; Clonetics, Cambrex, East, NJ) supplemented with 100 U/mL penicillin, 100 lg/mL streptomycin for 7 days. Cells were then trypsinized and seeded on porous polyester membranes (67 Five days later, the culture medium was removed from the upper compartment, and the epithelium was allowed to differentiate by using the differentiation medium consisting of 1:1 DMEM (Invitrogen) and BEBM (Clonetics), with the Clonetics complements for human Epidermal Growth Factor (hEGF) (0.5 ng/mL), epinephrine (5 g/mL), bovine pituitary extract (BPE) (0.13 mg/mL), hydrocortisone (0.5 g/mL), insulin (5 g/mL), triiodothyronine (6.5 g/mL), and transferrin (0.5 g/mL), and supplemented with 100 UI/mL penicillin, 100 g/mL streptomycin, 0.1 nM retinoic acid (Sigma-Aldrich), and 10% fetal bovine serum (FBS) (SigmaAldrich) in the basal compartment.
Immunofluorescent Staining and Confocal Microscopy
As previously described, 29 primary human sinonasal epithelial ALI cultures were grown to maturity (described above), washed three times with phosphate buffer saline (PBS), and fixed in 4% paraformaldehyde for 20 minutes at room temperature. The transwell permeable support was again washed three times with PBS prior to excision of the membrane containing the cells from its plastic supports. The membrane was immersed in Tris-buffered saline with 0.3% Triton X-100, 5% normal donkey serum, and 1% BSA for 60 minutes at room temperature to permeabilize the plasma membrane and block nonspecific binding sites. Two primary antibodies raised from different hosts were chosen for the double immunofluorescent staining: mouse monoclonal anti-b-Tubulin IV (1:1000; Abcam, Cambridge, MA) and rabbit polyclonal anti-T2R38 (1:500; Santa Cruz Biotech, Santa Cruz, CA). Visualization was carried out with Alex Fluora 488, Secondary antibodies were purchased from Molecular Probes (Eugene OR) (green)-conjugated donkey anti-mouse IgG for tubulin IV and Alex Fluora 594, Secondary antibodies were purchased from Molecular Probes (Eugene OR) (red)-conjugated donkey anti-rabbit IgG for T2R38. Both secondary antibodies (Invitrogen) were diluted at 1:500. The incubation time was overnight at 48C for primary antibodies and 75 minutes at room temperature for secondary antibodies, respectively. Counterstaining was done with Hoechst stain (SigmaAldrich, St. Louis, MO) (blue), a nuclear dye. Confocal images were acquired with Olympus Life Sciences Solutions (Waltham, MA) Fluoview System at the Z-axis step of 0.5 lm. Sequential scanning module was used to prevent bleed-through of fluorophores into other channels. Fig. 3 . Decreased cilia in sinonasal mucosa from a patient with CRS. Scanning electron micrograph of sinonasal mucosa obtained from the maxillary sinus from a patient with no CRS (A) compared to a patient with CRS (B). In the control patient, the lining of the sinus has the appearance of shag carpet completely covered by cilia, whereas in the CRS patient the surface has few ciliated cells. CRS 5 chronic rhinosinusitis.
Live-Cell Imaging of DAF-FM in Human ALI Cultures
As previously described, 29 DAF-FM imaging was performed according to standard methods using the 488 nm argon laser line of a Fluoview FV1000 laser scanning confocal system and IX-81 microscope (103, 0.3 NA UPlanFLN objective; Olympus). Cells were loaded with DAF-FM by incubation in DPBS containing 10 lM DAF-FM diacetate in PBS containing 5 lM 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO), a cell permeant NO scavenger (on the apical side Fig. 4 . Expression of T2R38 is localized to cilia. Prior to ciliogenesis, human sinonasal epithelial cells do not demonstrate expression of T2R38. ALI cultures were subjected to dual label immunofluorescence for type IV b-Tubulin (a marker for motile cilia) (green) and T2R38 (red). During the first week of differentiation (A-C), ALI cultures are nonciliated, but by day 9 (D) and more so on day 12, (E) cilia are present. Expression of T2R38 mirrors the appearance of cilia (yellow). ALI 5 air-liquid interface. only). After 30 minutes, cultures were copiously washed (at least 5 times) with PBS to remove all traces of unloaded DAF-FM. Cultures were then incubated for 15 minutes to allow for dye retention before imaging was performed. DAF-FM fluorescence images were acquired at 5-second intervals. Because the magnitudes of DAF-FM fluorescence changes are used to approximate NO production, care was taken to follow the loading protocol strictly to normalize dye loading and microscope/ software settings were identical for each experiment.
RESULTS
ALI cultures at day 0, 3, 6, 9, and 12 after transitioning to apical exposure to air were subjected to double immunofluorescence staining with type IV b-tubulin, a marker for motile cilia (green), and T2R38 (red). Merger of the images (yellow) confirms the localization of T2R38 to sinonasal cilia, demonstrating that expression of T2R38 is directly linked to ciliogenesis because no T2R38 expression is evident prior to cilia formation (days 0, 3, and 6) (Fig. 4) .
Further experiments were performed to investigate whether cilia are necessary for T2R38-mediated production of NO. Sinonasal ALI cultures derived from PAV/ PAV patients were stimulated with the T2R38 agonists PTC and the quorum-sensing molecule C12HSL at various time points during maturation (day 0, 3, 6, 9, and 12). As expected from the results above (Fig. 4) , T2R38-mediated NO production was not evident prior to cilia formation (Fig. 5) .
DISCUSSION
This study is additive to the broader body of work generated by our lab with regard to the role of the T2R38 receptor in CRS. Our findings indicate that T2R38, originally identified as a bitter taste receptor, is expressed in human sinonasal epithelial cells, where it triggers a rapid interkingdom signaling response bridging microbial secretions and the human upper airway epithelium, making it an integral component of upper respiratory early response defenses and acting well before Toll-like or Nod-like receptors. 49 When stimulated by AHLs, T2R38 elicits calcium-dependent NO production that increases ciliary beat frequency and mucus clearance. Additionally, this NO diffuses into the airway and contributes to innate antimicrobial effects. Furthermore, we demonstrated that upper airway epithelial cells from individuals with one or two nonfunctional T2R38 alleles (AVI) have significantly blunted NO and ciliary responses following exposure to gram-negative quorum-sensing molecules, and that these individuals are more likely to be infected with gram-negative bacteria such as Pseudomonas aeruginosa than those with two functional receptor alleles, 29 and to develop CRS necessitating surgical intervention. 25 The finding of this study demonstrating that cilia formation is necessary for T2R38 expression and function has broad implications in chronic rhinosinusitis where sinonasal ciliary integrity is compromised (Fig. 3) . This stresses the need for mucosal preservation surgery (Fig. 4.) , neither PTC nor C12HSL induced NO production. (D) On the ninth day of ALI culture maturation, as cilia begin to form, both PTC (left) and C12HSL (right) induced NO production, which was also apparent on day 12 (E). Direct comparison of NO produced at day 9 and day 12 (F) demonstrates statistically significant more NO produced on day 12 than day 9 (1-way ANOVA with Bonferonni post-test; P < 0.05 was considered statistically significant). and aggressive postoperative therapies to normalize the sinonasal mucosa. 50 A perplexing observation from this data is that many heterozygotes (PAV/AVI) behaved more like nonfunctional homozygotes (AVI/AVI) with regard to sinonasal defense and manifestation of CRS. 25, 27, 29 The range of PTC taste sensitivity within the heterozygote (PAV/AVI) population has been a scientific conundrum as well. The taste puzzle has been at least partially solved by the observation that heterozygous people differ in the amount of functional (PAV) mRNA that they express, and those who express little or no functional forms are phenotypically similar to people with a nontaster (AVI/ AVI) genotype, 51 a phenomenon known as allele-specific expression. Thus, the heterozygotes in the original data (Table I ) may have been skewed and were poor PAV expressers, which would explain both their low production of NO and susceptibility to CRS. The possibility of allele specific expression in the heterozygote population as an explanation for this finding is under investigation utilizing allele-specific and tissue-specific quantitative PCR.
CONCLUSION
Further prospective clinical studies of TAS2R38 genotype and CRS susceptibility, including the influence of TAS2R38 genotype on patient outcomes, are currently ongoing. However, the T2R38 pathway is already a potential therapeutic target to promote endogenous immune responses in patients with upper respiratory infections. One caveat, though, is that there would likely be a large subset of patients who would be suboptimally responsive to treatment with T2R38 agonists (i.e., PAV/AVI and AVI/ AVI individuals). It is thus still necessary to further define T2R38 signaling mechanisms in airway cells, as well as to identify other T2Rs that activate similar responses.
It is also likely that other T2R isoforms expressed in other airway cell types may have important clinical relevance. In particular, the genetics of T2Rs in nasal solitary chemosensory cells (SCCs) may play an important role in CRS susceptibility. As has recently been shown by our lab, taste receptors expressed in SCCs control antimicrobial peptide secretion in humans, 33 and others have shown that SCC control both breath-holding 52 and inflammation in the mouse nose. 53 Clinical consequences of taste-receptor genetics on SCCs remain to be determined. Additionally, the middle ear is lined by a ciliated epithelium, and preliminary studies suggest expression of T2Rs localizing to cilia in human middle ear mucosa. Thus, similar taste receptor genetics that are emerging in chronic rhinosinusitis may similarly be contributing to otitis media.
A better understanding of the T2R isoforms expressed in ciliated cells will speed identification of potential compounds that stimulate innate defenses. The role of T2Rs as global mediators of innate immunity was recently supported by a report demonstrating that T2R-expressing chemosensory cells in the rodent urethra respond to the bitter compounds, as well as heatinactivated uropathogenic E. coli; activation of these cells causes release of ACh to activate the bladder detrusor muscle. 54 Further investigation of T2Rs in innate immunity will likely result in significant clinical impact in the airway and other organ systems.
